본문 바로가기

Effects of Chemotherapy (Anthracyclin, Cyclophosphamide following Docetaxel Regimen) on Sleep, Anxiety, Depression, and Quality of Life in Patients with Breast Cancer

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q2
저널
ONCOLOGY103(11) · pp.974 · 2025
피인용
Web of Science 6Scopus 8
FWCI (Scopus)
1.86
JCR IF
JCR 2024 1.8
ISSN
0030-2414

저자

  1. 주수현제1저자Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Surg,Yangsan Hosp, Yangsan, South Korea
  2. 정윤주Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Surg,Yangsan Hosp, Yangsan, South Korea
  3. 이승주Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Surg,Yangsan Hosp, Yangsan, South Korea
  4. 강석경Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Surg,Yangsan Hosp, Yangsan, South Korea
  5. 유미리Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Surg,Yangsan Hosp, Yangsan, South Korea
  6. 김지연
  7. 남경진Pusan Natl Univ, Sch Med, Yangsan Hosp, Dept Radiol, Pusan, South Korea
  8. 이계영Pusan Natl Univ, Sch Med, Yangsan Hosp, Dept Radiol, Pusan, South Korea
  9. 주지현
  10. 전영경Pusan Natl Univ, Sch Med, Dept Hematol & Oncol, Yangsan Hosp, Yangsan, South Korea
  11. 김재준Pusan Natl Univ, Sch Med, Yangsan Hosp, Dept Pathol, Yangsan, South Korea
  12. 김지훈Pusan Natl Univ, Sch Med, Dept Radiat Oncol, Yangsan Hosp, Yangsan, South Korea
  13. 남수봉Pusan Natl Univ, Yangsan Hosp, Dept Plast & Reconstruct Surg, Sch Med, Yangsan, South Korea
  14. 윤미숙Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Div Biostat, Yangsan, South Korea
  15. 김현열교신저자Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Surg,Yangsan Hosp, Yangsan, South Korea

초록

Introduction: Chemotherapy can cause sleep disorders, anxiety, depression, and decreased quality of life (QoL). This study aimed to compare sleep, anxiety, depression, and QoL during chemotherapy in patients with breast cancer to provide appropriate treatment at the appropriate time. Methods: This prospective study included patients with breast cancer who received chemotherapy at Pusan National University Yangsan Hospital. We used three self-reporting questionnaires regarding quality of sleep (QoS), anxiety, depression, and QoL. QoL was measured using the Pittsburgh Sleep Quality Index, anxiety using the Beck Anxiety Inventory, depression using the Beck Depression Inventory, and QoL using the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form. Patients were assessed before, after, and during chemotherapy. Results: In total, 55 patients were enrolled in this study, of whom 49 completed three self-reporting questionnaires. Anxiety, depression, QoS, and QoL varied during the study. Anxiety, depression, and QoL scores were lowest at the end of chemotherapy (p < 0.005). However, QoS scores were lowest at the beginning of chemotherapy (p < 0.005). Cancer subtype (triple-negative vs. luminal type), T stage, type of breast surgery (breast-conserving surgery vs. mastectomy), and chemotherapy type (adjuvant vs. neoadjuvant) did not show a relationship with QoL, anxiety, depression, or QoS; however, age exhibited differences in all four areas. Patients aged >50 years experiencedmore sleep disturbances, anxiety, depression, and a decreased QoL. In addition, anxiety was increased during chemotherapy in patients with lymph node metastasis. Conclusions: Patients with breast cancer experience sleep disturbances, anxiety, depression, and low QoL during chemotherapy. During chemotherapy, these symptoms are often overlooked owing to the side effects of chemotherapy. Proper treatment and emotional support will help patients improve their QoL, anxiety, depression, and QoL.

키워드

AnxietyDepressionEffects of chemotherapyQuality of lifeSleepMENOPAUSEWOMENFATIGUE

식별자

Scopus EID
2-s2.0-86000515170
WoS UID
001438731400001